New Imodium product name
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Healthcare gives a new name, ImodiumMulti-Symptom Relief, to its OTC combination of two anti-diarrheal medicines - loperamide hydrochloride and simethicone. The Fort Washington, Pa.-based Johnson & Johnson business says in an Oct. 16 release that loperamide HCI reduces fluid secretion and simethicone eases the symptoms of gas, cramps, bloating and pressure. Two double-blind, placebo-controlled studies found the drug shortened bouts of diarrhea and relieved abdominal discomfort. McNeil previously marketed the product as Imodium Advanced
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.